Cargando…
N-(2′-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Inhibits HDAC1 and Increases the Translocation of HMGB1 Levels in Human Cervical Cancer Cells
N-(2′-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) is a VPA derivative designed to be a histone deacetylase (HDAC) inhibitor. HO-AAVPA has better antiproliferative effect than VPA in cancer cell lines. Therefore, in this work, the inhibitory effect of HO-AAVPA on HDAC1, HDAC6, and HDAC8 was determi...
Autores principales: | Sixto-López, Yudibeth, Rosales-Hernández, Martha Cecilia, Contis-Montes de Oca, Arturo, Fragoso-Morales, Leticia Guadalupe, Mendieta-Wejebe, Jessica Elena, Correa-Basurto, Ana María, Abarca-Rojano, Edgar, Correa-Basurto, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461584/ https://www.ncbi.nlm.nih.gov/pubmed/32824279 http://dx.doi.org/10.3390/ijms21165873 |
Ejemplares similares
-
N-(2′-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells
por: Contis-Montes de Oca, Arturo, et al.
Publicado: (2018) -
Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells
por: Contis-Montes de Oca, Arturo, et al.
Publicado: (2019) -
PAMAM-G4 protect the N-(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) and maintain its antiproliferative effects on MCF-7
por: Ortiz-Morales, Alma Alicia, et al.
Publicado: (2023) -
Hepatotoxic Evaluation of N-(2-Hydroxyphenyl)-2-Propylpentanamide: A Novel Derivative of Valproic Acid for the Treatment of Cancer
por: Correa Basurto, Ana María, et al.
Publicado: (2023) -
Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines
por: Estrada-Pérez, Alan Rubén, et al.
Publicado: (2023)